Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Wiendl

Showing results (1-10 of 695) with videos related to

Pageof 70
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
Idiopathic inflammatory myopathies: current and future therapeutic optionsHeinz Wiendl
Current Opinion in Neurology|April 11, 2012
Neuroinflammation: the world is not enoughHeinz Wiendl
Human Immunology|April 3, 2007
HLA-G in the nervous systemHeinz Wiendl
Nature Reviews. Neurology|September 9, 2017
Cladribine - an old newcomer for pulsed immune reconstitution in MSHeinz Wiendl
Science Translational Medicine|November 8, 2023
Learning CNS immunopathology from therapeutic interventionsNicholas Schwab, Heinz Wiendl
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2025
'Anti-B cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation': YesRick Dersch, Heinz Wiendl
Neurology|March 18, 2009
Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successesHeinz Wiendl, Reinhard Hohlfeld
Nature Reviews. Neurology|January 30, 2013
Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MSHeinz Wiendl, Bernd Kieseier
Expert Opinion on Biological Therapy|March 26, 2013
Monoclonal antibodies in neuroinflammatory diseasesLuisa Klotz, Heinz Wiendl
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2020
4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect - NoKerstin Göbel, Heinz Wiendl
Pageof 70

Showing results (1-10 of 695) with videos related to

Sort By:
Pageof 70
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
Idiopathic inflammatory myopathies: current and future therapeutic optionsHeinz Wiendl
Current Opinion in Neurology|April 11, 2012
Neuroinflammation: the world is not enoughHeinz Wiendl
Human Immunology|April 3, 2007
HLA-G in the nervous systemHeinz Wiendl
Nature Reviews. Neurology|September 9, 2017
Cladribine - an old newcomer for pulsed immune reconstitution in MSHeinz Wiendl
Science Translational Medicine|November 8, 2023
Learning CNS immunopathology from therapeutic interventionsNicholas Schwab, Heinz Wiendl
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2025
'Anti-B cell CAR-T therapy in multiple sclerosis is simply a more profound immunoablation': YesRick Dersch, Heinz Wiendl
Neurology|March 18, 2009
Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successesHeinz Wiendl, Reinhard Hohlfeld
Nature Reviews. Neurology|January 30, 2013
Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MSHeinz Wiendl, Bernd Kieseier
Expert Opinion on Biological Therapy|March 26, 2013
Monoclonal antibodies in neuroinflammatory diseasesLuisa Klotz, Heinz Wiendl
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2020
4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect - NoKerstin Göbel, Heinz Wiendl
Pageof 70